Common Stock (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Aggregate Warrants | As of March 31, 2026, the following aggregate warrants to purchase shares of the Company’s common stock were issued and outstanding:
(1) In September 2024, 1,750,000 shares of common stock subject to outstanding pre-funded warrants were cashless exercised and 1,749,993 shares of common stock were issued. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Number of Common Stock Reserved for Future Issuance | The Company had reserved common stock for future issuance as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||